Elite PharmaceuticalsELTP 
$0.349.68%24h
9.68%24h
Global rank13755
Market cap$344.39M
Change 7d21.43%
YTD Performance142.86%
SP500 benchmarkOutperform
P/E96.70
P/S10.08
Revenue$34.16M
Earnings$3.56M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Elite Pharmaceuticals (ELTP)
As of September 2024, Elite Pharmaceuticals has a market cap of $344.39M. This makes Elite Pharmaceuticals the world's 13755th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Elite Pharmaceuticals from 2000 to 2024
-
Value:-
Market cap history of Elite Pharmaceuticals from 2000 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $196.72M | 38.72% |
| 2023 | $141.81M | 366.67% |
| 2022 | $30.39M | 0.00% |
| 2021 | $30.39M | -40.00% |
| 2020 | $50.65M | -44.44% |
| 2019 | $91.16M | 28.57% |
| 2018 | $70.90M | -22.22% |
| 2017 | $91.16M | -40.00% |
| 2016 | $151.94M | -63.41% |
| 2015 | $415.29M | 78.26% |
| 2014 | $232.97M | 91.67% |
| 2013 | $121.55M | 50.00% |
| 2012 | $81.03M | 14.29% |
| 2011 | $70.90M | 75.00% |
| 2010 | $40.52M | -63.64% |
| 2009 | $111.42M | 57.14% |
| 2008 | $70.90M | -96.63% |
| 2007 | $2.11B | -4.59% |
| 2006 | $2.21B | 18.48% |
| 2005 | $1.86B | -49.86% |
| 2004 | $3.72B | 22.33% |
| 2003 | $3.04B | 58.73% |
| 2002 | $1.91B | -70.92% |
| 2001 | $6.58B | 4.00% |
| 2000 | $6.33B | - |
ELTP Market Cap Today is $344.39M 9.68% - 10 Sept 2024
View largest stocks by market cap 
